Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.29%
1,096.98
+3.17
+0.29%
—1,093.811,096.521,100.221,094.01——
SIXC
Communications
SIXC
Communications
SIXC
+0.37%
611.04
+2.27
+0.37%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-0.94%
1,243.06
-11.75
-0.94%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.68%
1,749.07
-12.04
-0.68%
—1,761.111,764.271,766.881,748.79——
SIXM
Financials
SIXM
Financials
SIXM
+0.57%
646.25
+3.67
+0.57%
—642.58644.87648.48642.88——
SIXR
Staples
SIXR
Staples
SIXR
+0.66%
856.79
+5.66
+0.66%
—851.13855.66858.75853.75——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.04%
218.07
+0.090
+0.04%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+0.85%
3,239.18
+27.35
+0.85%
—3,211.833,227.213,266.903,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.56%
954.28
+5.30
+0.56%
—948.98948.58957.83944.72——
SIXV
Health care
SIXV
Health care
SIXV
+0.09%
1,475.88
+1.36
+0.09%
—1,474.521,479.031,481.041,472.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.73%
2,409.49
+17.37
+0.73%
—2,392.122,396.952,421.222,382.32——
MMQ0:FRA
Definium Therapeutics Inc
€17.20
-3.10%
(-0.55) 1D
Apr 30, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for MMQ0...
Open
€17.20
High
€17.20
Low
€17.20
Mkt. cap
2.39B
Avg. vol.
257.00
Volume
0.00
52-wk high
€23.00
52-wk low
€12.81
No. of employees
106
News stories
From sources across the web
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
23.36M
29.81M
30.98M
33.52M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.80M
11.09M
14.69M
14.06M
Operating expense
32.16M
40.90M
45.67M
47.58M
Total operating expenses
32.16M
40.90M
45.67M
47.58M
Operating income
-32.16M
-40.90M
-45.67M
-47.58M
Other non operating income
7.00M
-2.23M
-22.54M
-5.06M
EBT including unusual items
-23.35M
-42.74M
-67.26M
-50.44M
EBT excluding unusual items
-23.35M
-42.74M
-67.26M
-50.44M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-23.35M
-42.74M
-67.26M
-50.44M
Net profit margin
-
-
-
-
Earnings per share
-0.35
-0.50
-0.78
-
Interest and investment income
2.43M
2.77M
2.26M
3.49M
Interest expense
-602.00K
-2.34M
-1.27M
-1.27M
Net interest expenses
1.83M
436.00K
988.00K
2.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
-32.15M
-40.90M
-45.66M
-47.57M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer